Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 360

1.

Pathogenesis of Pancreatic Cancer-Related Diabetes Mellitus: Quo Vadis?

Korc M.

Pancreas. 2019 May/Jun;48(5):594-597. doi: 10.1097/MPA.0000000000001300. No abstract available.

PMID:
31090659
2.

Evaluation of a Mixed Meal Test for Diagnosis and Characterization of PancrEaTogEniC DiabeTes Secondary to Pancreatic Cancer and Chronic Pancreatitis: Rationale and Methodology for the DETECT Study From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer.

Hart PA, Andersen DK, Mather KJ, Castonguay AC, Bajaj M, Bellin MD, Bradley D, Contreras N, Habtezion A, Korc M, Kudva Y, Petrov MS, Whitcomb DC, Yadav D, Yuan Y, Rinaudo JAS, Srivastava S, Serrano J, Goodarzi MO; Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC).

Pancreas. 2018 Nov/Dec;47(10):1239-1243. doi: 10.1097/MPA.0000000000001168. Erratum in: Pancreas. 2019 Jan;48(1):e9.

PMID:
30325863
3.

Circulating Thrombospondin-2 enhances prediction of malignant intraductal papillary mucinous neoplasm.

Simpson RE, Yip-Schneider MT, Wu H, Fan H, Liu Z, Korc M, Zhang J, Schmidt CM.

Am J Surg. 2019 Mar;217(3):425-428. doi: 10.1016/j.amjsurg.2018.08.026. Epub 2018 Sep 7.

PMID:
30293901
4.

Circulating Leptin and Branched Chain Amino Acids-Correlation with Intraductal Papillary Mucinous Neoplasm Dysplastic Grade.

Yip-Schneider MT, Simpson R, Carr RA, Wu H, Fan H, Liu Z, Korc M, Zhang J, Schmidt CM.

J Gastrointest Surg. 2019 May;23(5):966-974. doi: 10.1007/s11605-018-3963-y. Epub 2018 Sep 13.

PMID:
30215202
5.

Differentiation therapy and the mechanisms that terminate cancer cell proliferation without harming normal cells.

Enane FO, Saunthararajah Y, Korc M.

Cell Death Dis. 2018 Sep 6;9(9):912. doi: 10.1038/s41419-018-0919-9. Review.

6.

Designer hydrogels: Shedding light on the physical chemistry of the pancreatic cancer microenvironment.

Lin CC, Korc M.

Cancer Lett. 2018 Nov 1;436:22-27. doi: 10.1016/j.canlet.2018.08.008. Epub 2018 Aug 14.

PMID:
30118843
7.

Beyond Kras: MYC Rules in Pancreatic Cancer.

Korc M.

Cell Mol Gastroenterol Hepatol. 2018 May 26;6(2):223-224. doi: 10.1016/j.jcmgh.2018.04.009. eCollection 2018. No abstract available.

8.

The Interface of Pancreatic Cancer With Diabetes, Obesity, and Inflammation: Research Gaps and Opportunities: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Abbruzzese JL, Andersen DK, Borrebaeck CAK, Chari ST, Costello E, Cruz-Monserrate Z, Eibl G, Engleman EG, Fisher WE, Habtezion A, Kim SK, Korc M, Logsdon C, Lyssiotis CA, Pandol SJ, Rustgi A, Wolfe BM, Zheng L, Powers AC.

Pancreas. 2018 May/Jun;47(5):516-525. doi: 10.1097/MPA.0000000000001037.

9.

Correction: DeltaNp63alpha-Mediated Induction of Epidermal Growth Factor Receptor Promotes Pancreatic Cancer Cell Growth and Chemoresistance.

Danilov AV, Neupane D, Nagaraja AS, Feofanova EV, Humphries LA, DiRenzo J, Korc M.

PLoS One. 2018 Feb 8;13(2):e0192927. doi: 10.1371/journal.pone.0192927. eCollection 2018.

10.

Biomimetic and enzyme-responsive dynamic hydrogels for studying cell-matrix interactions in pancreatic ductal adenocarcinoma.

Liu HY, Korc M, Lin CC.

Biomaterials. 2018 Apr;160:24-36. doi: 10.1016/j.biomaterials.2018.01.012. Epub 2018 Jan 8.

11.

Safety and Efficacy of AAV Retrograde Pancreatic Ductal Gene Delivery in Normal and Pancreatic Cancer Mice.

Quirin KA, Kwon JJ, Alioufi A, Factora T, Temm CJ, Jacobsen M, Sandusky GE, Shontz K, Chicoine LG, Clark KR, Mendell JT, Korc M, Kota J.

Mol Ther Methods Clin Dev. 2017 Sep 30;8:8-20. doi: 10.1016/j.omtm.2017.09.006. eCollection 2018 Mar 16.

12.

Cancer-associated cachexia.

Baracos VE, Martin L, Korc M, Guttridge DC, Fearon KCH.

Nat Rev Dis Primers. 2018 Jan 18;4:17105. doi: 10.1038/nrdp.2017.105. Review.

PMID:
29345251
13.

Tobacco and alcohol as risk factors for pancreatic cancer.

Korc M, Jeon CY, Edderkaoui M, Pandol SJ, Petrov MS; Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC).

Best Pract Res Clin Gastroenterol. 2017 Oct;31(5):529-536. doi: 10.1016/j.bpg.2017.09.001. Epub 2017 Sep 6. Review.

14.

Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer.

Eibl G, Cruz-Monserrate Z, Korc M, Petrov MS, Goodarzi MO, Fisher WE, Habtezion A, Lugea A, Pandol SJ, Hart PA, Andersen DK; Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer.

J Acad Nutr Diet. 2018 Apr;118(4):555-567. doi: 10.1016/j.jand.2017.07.005. Epub 2017 Sep 12.

15.

Gastrin-Releasing Peptide and Glucose Metabolism Following Pancreatitis.

Pendharkar SA, Drury M, Walia M, Korc M, Petrov MS.

Gastroenterology Res. 2017 Aug;10(4):224-234. doi: 10.14740/gr890w. Epub 2017 Aug 31.

16.

The United States-Mexico border environmental public health: the challenges of working with two systems.

Carrillo G, Uribe F, Lucio R, Ramirez Lopez A, Korc M.

Rev Panam Salud Publica. 2017 Aug 21;41:e98.

17.

Transportation Matters: A Health Impact Assessment in Rural New Mexico.

Del Rio M, Hargrove WL, Tomaka J, Korc M.

Int J Environ Res Public Health. 2017 Jun 13;14(6). pii: E629. doi: 10.3390/ijerph14060629.

18.

microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-β actions.

Ouyang H, Gore J, Deitz S, Korc M.

Oncogene. 2017 Aug 24;36(34):4952. doi: 10.1038/onc.2017.190. Epub 2017 Jun 12.

19.

Adapting AlphaLISA high throughput screen to discover a novel small-molecule inhibitor targeting protein arginine methyltransferase 5 in pancreatic and colorectal cancers.

Prabhu L, Wei H, Chen L, Demir Ö, Sandusky G, Sun E, Wang J, Mo J, Zeng L, Fishel M, Safa A, Amaro R, Korc M, Zhang ZY, Lu T.

Oncotarget. 2017 Jun 20;8(25):39963-39977. doi: 10.18632/oncotarget.18102.

20.

Plasma microRNAs as biomarkers of pancreatic cancer risk in a prospective cohort study.

Duell EJ, Lujan-Barroso L, Sala N, Deitz McElyea S, Overvad K, Tjonneland A, Olsen A, Weiderpass E, Busund LT, Moi L, Muller D, Vineis P, Aune D, Matullo G, Naccarati A, Panico S, Tagliabue G, Tumino R, Palli D, Kaaks R, Katzke VA, Boeing H, Bueno-de-Mesquita HBA, Peeters PH, Trichopoulou A, Lagiou P, Kotanidou A, Travis RC, Wareham N, Khaw KT, Ramon Quiros J, Rodríguez-Barranco M, Dorronsoro M, Chirlaque MD, Ardanaz E, Severi G, Boutron-Ruault MC, Rebours V, Brennan P, Gunter M, Scelo G, Cote G, Sherman S, Korc M.

Int J Cancer. 2017 Sep 1;141(5):905-915. doi: 10.1002/ijc.30790. Epub 2017 Jun 12.

21.

Informative Patterns of Health-Care Utilization Prior to the Diagnosis of Pancreatic Ductal Adenocarcinoma.

Coté GA, Xu H, Easler JJ, Imler TD, Teal E, Sherman S, Korc M.

Am J Epidemiol. 2017 Oct 15;186(8):944-951. doi: 10.1093/aje/kwx168.

22.

Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer.

Andersen DK, Korc M, Petersen GM, Eibl G, Li D, Rickels MR, Chari ST, Abbruzzese JL.

Diabetes. 2017 May;66(5):1103-1110. doi: 10.2337/db16-1477.

23.

Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer.

Hart PA, Bellin MD, Andersen DK, Bradley D, Cruz-Monserrate Z, Forsmark CE, Goodarzi MO, Habtezion A, Korc M, Kudva YC, Pandol SJ, Yadav D, Chari ST; Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer(CPDPC).

Lancet Gastroenterol Hepatol. 2016 Nov;1(3):226-237. doi: 10.1016/S2468-1253(16)30106-6. Epub 2016 Oct 12. Review.

24.

A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer.

Lai X, Wang M, McElyea SD, Sherman S, House M, Korc M.

Cancer Lett. 2017 May 1;393:86-93. doi: 10.1016/j.canlet.2017.02.019. Epub 2017 Feb 20.

25.

Sugar-Coated Proteins Pave the Way to Improving Pancreatic Cancer Diagnosis.

Korc M.

Cell Mol Gastroenterol Hepatol. 2016 Jan 28;2(2):118-119. doi: 10.1016/j.jcmgh.2016.01.001. eCollection 2016 Mar. No abstract available.

26.

Pancreatic cancer: Stroma and its current and emerging targeted therapies.

Kota J, Hancock J, Kwon J, Korc M.

Cancer Lett. 2017 Apr 10;391:38-49. doi: 10.1016/j.canlet.2016.12.035. Epub 2017 Jan 14. Review.

PMID:
28093284
27.

Modular and Adaptable Tumor Niche Prepared from Visible Light Initiated Thiol-Norbornene Photopolymerization.

Shih H, Greene T, Korc M, Lin CC.

Biomacromolecules. 2016 Dec 12;17(12):3872-3882. Epub 2016 Nov 11.

28.

Regulation of HIF1α under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer Models.

Logsdon DP, Grimard M, Luo M, Shahda S, Jiang Y, Tong Y, Yu Z, Zyromski N, Schipani E, Carta F, Supuran CT, Korc M, Ivan M, Kelley MR, Fishel ML.

Mol Cancer Ther. 2016 Nov;15(11):2722-2732. Epub 2016 Aug 17.

29.

Enzyme-mediated stiffening hydrogels for probing activation of pancreatic stellate cells.

Liu HY, Greene T, Lin TY, Dawes CS, Korc M, Lin CC.

Acta Biomater. 2017 Jan 15;48:258-269. doi: 10.1016/j.actbio.2016.10.027. Epub 2016 Oct 18.

30.

Interventions that facilitate sustainable development by preventing toxic exposure to chemicals: an overview of systematic reviews.

Haby MM, Soares A, Chapman E, Clark R, Korc M, Galvão LA.

Rev Panam Salud Publica. 2016 Jun;39(6):378-386. Review.

PMID:
27706431
31.

Novel role of miR-29a in pancreatic cancer autophagy and its therapeutic potential.

Kwon JJ, Willy JA, Quirin KA, Wek RC, Korc M, Yin XM, Kota J.

Oncotarget. 2016 Nov 1;7(44):71635-71650. doi: 10.18632/oncotarget.11928.

32.

MicroRNA Expression in a Readily Accessible Common Hepatic Artery Lymph Node Predicts Time to Pancreatic Cancer Recurrence Postresection.

Nguyen HV, Gore J, Zhong X, Savant SS, Deitz-McElyea S, Schmidt CM, House MG, Korc M.

J Gastrointest Surg. 2016 Oct;20(10):1699-706. doi: 10.1007/s11605-016-3208-x. Epub 2016 Jul 25.

33.

RelA: a tale of a stitch in time.

Korc M.

J Clin Invest. 2016 Aug 1;126(8):2799-801. doi: 10.1172/JCI89156. Epub 2016 Jul 25.

34.

Pancreatic cancer-associated retinoblastoma 1 dysfunction enables TGF-β to promote proliferation.

Gore AJ, Deitz SL, Palam LR, Craven KE, Korc M.

J Clin Invest. 2016 Jul 1;126(7):2774. doi: 10.1172/JCI88840. Epub 2016 Jul 1. No abstract available.

35.

Combined targeting of TGF-β, EGFR and HER2 suppresses lymphangiogenesis and metastasis in a pancreatic cancer model.

Gore J, Imasuen-Williams IE, Conteh AM, Craven KE, Cheng M, Korc M.

Cancer Lett. 2016 Aug 28;379(1):143-53. doi: 10.1016/j.canlet.2016.05.037. Epub 2016 Jun 3.

36.

Pancreatic cancer.

Kleeff J, Korc M, Apte M, La Vecchia C, Johnson CD, Biankin AV, Neale RE, Tempero M, Tuveson DA, Hruban RH, Neoptolemos JP.

Nat Rev Dis Primers. 2016 Apr 21;2:16022. doi: 10.1038/nrdp.2016.22. Review.

PMID:
27158978
37.

Metastatic Pancreatic Adenocarcinoma After Total Pancreatectomy Islet Autotransplantation for Chronic Pancreatitis.

Muratore S, Zeng X, Korc M, McElyea S, Wilhelm J, Bellin M, Beilman G.

Am J Transplant. 2016 Sep;16(9):2747-52. doi: 10.1111/ajt.13851. Epub 2016 Jun 27.

38.

Overview of pre-clinical and clinical studies targeting angiogenesis in pancreatic ductal adenocarcinoma.

Craven KE, Gore J, Korc M.

Cancer Lett. 2016 Oct 10;381(1):201-10. doi: 10.1016/j.canlet.2015.11.047. Epub 2015 Dec 23. Review.

39.

Recapitulation of complex transport and action of drugs at the tumor microenvironment using tumor-microenvironment-on-chip.

Han B, Qu C, Park K, Konieczny SF, Korc M.

Cancer Lett. 2016 Sep 28;380(1):319-29. doi: 10.1016/j.canlet.2015.12.003. Epub 2015 Dec 10. Review.

40.

Angiogenic gene signature in human pancreatic cancer correlates with TGF-beta and inflammatory transcriptomes.

Craven KE, Gore J, Wilson JL, Korc M.

Oncotarget. 2016 Jan 5;7(1):323-41. doi: 10.18632/oncotarget.6345.

41.

Integrated stress response is critical for gemcitabine resistance in pancreatic ductal adenocarcinoma.

Palam LR, Gore J, Craven KE, Wilson JL, Korc M.

Cell Death Dis. 2015 Oct 15;6:e1913. doi: 10.1038/cddis.2015.264.

42.

Label-Free Nanoplasmonic-Based Short Noncoding RNA Sensing at Attomolar Concentrations Allows for Quantitative and Highly Specific Assay of MicroRNA-10b in Biological Fluids and Circulating Exosomes.

Joshi GK, Deitz-McElyea S, Liyanage T, Lawrence K, Mali S, Sardar R, Korc M.

ACS Nano. 2015 Nov 24;9(11):11075-89. doi: 10.1021/acsnano.5b04527. Epub 2015 Oct 7.

43.

Pathophysiological role of microRNA-29 in pancreatic cancer stroma.

Kwon JJ, Nabinger SC, Vega Z, Sahu SS, Alluri RK, Abdul-Sater Z, Yu Z, Gore J, Nalepa G, Saxena R, Korc M, Kota J.

Sci Rep. 2015 Jun 22;5:11450. doi: 10.1038/srep11450.

44.

Response to Le Large et al.

Cote GA, Gore AJ, McElyea SD, Xu H, Sherman S, Korc M.

Am J Gastroenterol. 2015 May;110(5):769-70. doi: 10.1038/ajg.2015.82. No abstract available.

PMID:
25942303
45.

Healthy vinton: a health impact assessment focused on water and sanitation in a small rural town on the US-Mexico border.

Hargrove WL, Juárez-Carillo PM, Korc M.

Int J Environ Res Public Health. 2015 Apr 7;12(4):3864-88. doi: 10.3390/ijerph120403864.

46.

TCGA data and patient-derived orthotopic xenografts highlight pancreatic cancer-associated angiogenesis.

Gore J, Craven KE, Wilson JL, Cote GA, Cheng M, Nguyen HV, Cramer HM, Sherman S, Korc M.

Oncotarget. 2015 Apr 10;6(10):7504-21.

47.

Pancreatic cancer-associated diabetes is an "exosomopathy".

Korc M.

Clin Cancer Res. 2015 Apr 1;21(7):1508-10. doi: 10.1158/1078-0432.CCR-14-2990. Epub 2015 Feb 2.

48.

Critical role of NF-κB in pancreatic cancer.

Prabhu L, Mundade R, Korc M, Loehrer PJ, Lu T.

Oncotarget. 2014 Nov 30;5(22):10969-75. Review.

49.

Longitudinal Bioluminescence Imaging of Primary Versus Abdominal Metastatic Tumor Growth in Orthotopic Pancreatic Tumor Models in NSG Mice.

Shannon HE, Fishel ML, Xie J, Gu D, McCarthy BP, Riley AA, Sinn AL, Silver JM, Peterman K, Kelley MR, Hanenberg H, Korc M, Pollok KE, Territo PR.

Pancreas. 2015 Jan;44(1):64-75. doi: 10.1097/MPA.0000000000000238.

50.

Highly specific plasmonic biosensors for ultrasensitive microRNA detection in plasma from pancreatic cancer patients.

Joshi GK, Deitz-McElyea S, Johnson M, Mali S, Korc M, Sardar R.

Nano Lett. 2014 Dec 10;14(12):6955-63. doi: 10.1021/nl503220s. Epub 2014 Nov 7.

Supplemental Content

Support Center